SOPHiA GENETICS S.A. (SOPH) Insider Trading

Over the last 3 months, SOPH insiders made 1 open-market buy and 52 sales, a net sale of -$2.9M (SEC Form 4). Over the last 6 months, 30 institutions increased and 24 reduced their position (13F).

Insider Activity

Sentiment
4/100
Buys (3m)
1
Sells (3m)
52
Net (3m)
-$2.9M
Insiders buying
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Jul
Aug
Context3-month price +65.6%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Aug 31, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell10,000$8.91
Aug 26, 2026Verma Abhimanyuofficer: Chief Technology OfficerSell5,000$8.20
Aug 26, 2026HIBBS KATHY LdirectorSell6,250$8.68
Aug 26, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$8.68
Aug 21, 2026Valente Manuelaofficer: Chief People OfficerSell10,000$7.94
Aug 21, 2026Valente Manuelaofficer: Chief People OfficerOption10,000$3.20
Aug 21, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell5,408$8.40
Aug 21, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell4,592$8.41
Aug 21, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell10,000$7.94
Aug 14, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell4,000$7.52
Aug 14, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$7.52
Aug 10, 2026Camblong Jurgidirector, officer: Executive ChairmanSell20,000$7.23
Aug 10, 2026Camblong Jurgidirector, officer: Executive ChairmanSell8,500$7.61
Aug 10, 2026Verma Abhimanyuofficer: Chief Technology OfficerSell5,000$7.60
Aug 7, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell10,000$7.48
Aug 7, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell7,000$7.02
Aug 7, 2026Xu Zhenyuofficer: Chief Scientific OfficerOption7,000$3.28
Aug 7, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell3,000$7.00
Aug 7, 2026Xu Zhenyuofficer: Chief Scientific OfficerOption3,000$3.28
Aug 5, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell10,000$6.92
Aug 5, 2026Camblong Jurgidirector, officer: Executive ChairmanSell20,000$6.92
Aug 5, 2026Verma Abhimanyuofficer: Chief Technology OfficerSell5,000$6.95
Jul 28, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$5.66
Jul 22, 2026Camblong Jurgidirector, officer: Executive ChairmanOption4,581$3.16
Jul 22, 2026Camblong Jurgidirector, officer: Executive ChairmanSell20,000$6.63
Jul 22, 2026Camblong Jurgidirector, officer: Executive ChairmanSell4,581$6.17
Jul 22, 2026Camblong Jurgidirector, officer: Executive ChairmanSell19,800$6.32
Jul 14, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell4,000$5.70
Jul 14, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$5.70
Jul 14, 2026Camblong Jurgidirector, officer: Executive ChairmanSell8,500$5.62

Source: SOPH SEC Form 4 filings, latest Aug 31, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their SOPH positions over the last 6 months (SEC Form 13F).

Increased
30
New positions
44
Reduced
24
Sold out
3
Largest moves
InstitutionActionSharesFiled
GENERATION INVESTMENT MANAGEMENT LLPUnchanged6.8MAug 10, 2026
GENERATION INVESTMENT MANAGEMENT LLPUnchanged6.8MMay 14, 2026
AIGH Capital Management LLCNew Position4.0MAug 7, 2026
AKRE CAPITAL MANAGEMENT LLCUnchanged3.7MMay 14, 2026
AKRE CAPITAL MANAGEMENT LLCUnchanged3.7MAug 14, 2026
ROYCE & ASSOCIATES LPIncreased3.4MAug 14, 2026
PRINCIPAL FINANCIAL GROUP INCIncreased2.4MAug 4, 2026
AMERIPRISE FINANCIAL INCNew Position2.2MAug 14, 2026
BANQUE PICTET & CIE SAUnchanged2.2MJul 24, 2026
BANQUE PICTET & CIE SAUnchanged2.2MApr 14, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.New Position1.9MMay 14, 2026
ROYCE & ASSOCIATES LPIncreased1.8MMay 12, 2026
AWM Investment Company, Inc.New Position1.7MAug 14, 2026
Soleus Capital Management, L.P.Reduced1.6MAug 11, 2026
SILVERCREST ASSET MANAGEMENT GROUP LLCNew Position1.4MAug 14, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.